Cory Kasimov
Stock Analyst at Evercore ISI
(4.87)
# 346
Out of 5,028 analysts
1016
Total ratings
57%
Success rate
18.4%
Average return
Main Sectors:
Stocks Rated by Cory Kasimov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Reiterated: Buy | $34 | $17.27 | +96.87% | 12 | Sep 29, 2026 | |
| BNTC Benitec Biopharma | Reiterated: Buy | $25 | $9.23 | +170.86% | 2 | Sep 15, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $65 → $72 | $43.40 | +65.90% | 3 | Sep 15, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $130 | $66.14 | +96.55% | 20 | Sep 14, 2026 | |
| MRNA Moderna | Reiterated: Hold | $50 → $80 | $203.21 | -60.63% | 49 | Sep 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $325 | $219.89 | +47.89% | 8 | Aug 31, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $100 | $62.70 | +59.49% | 12 | Aug 31, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $230 → $320 | $207.68 | +54.08% | 7 | Aug 27, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $210 → $215 | $144.21 | +49.09% | 17 | Aug 17, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $21.17 | +88.95% | 8 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $57.54 | +108.55% | 84 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $40.30 | +36.48% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $37.57 | +112.94% | 7 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $22 | $11.78 | +86.76% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $25.67 | +75.30% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $97.64 | +33.14% | 32 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $12.49 | +100.16% | 5 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $535 | $503.50 | +6.26% | 61 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $30.59 | +63.45% | 1 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $875 → $825 | $726.47 | +13.56% | 77 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $15 | $4.84 | +209.92% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $27.86 | +97.42% | 7 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 → $128 | $14.50 | n/a | 47 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 → $84 | $15.20 | n/a | 26 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $33 | $42.76 | n/a | 48 | Jul 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $219 → $221 | $223.59 | n/a | 74 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $19 | $20.11 | n/a | 48 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $11 | $2.88 | n/a | 4 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $20 | $1.50 | n/a | 17 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $19 → $16 | $2.79 | n/a | 25 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $235 → $227 | $402.98 | n/a | 62 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $98 → $86 | $114.13 | n/a | 54 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $18.78 | n/a | 8 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $18.91 | n/a | 3 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $74 | $144.63 | n/a | 59 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $9.67 | n/a | 38 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $81.44 | n/a | 1 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.17 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.29 | n/a | 13 | Jun 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $3.82 | n/a | 14 | May 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $384 → $100 | $1,143.12 | n/a | 2 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $276.72 | $8.42 | n/a | 1 | Dec 15, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $0.1442 | n/a | 6 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.7953 | n/a | 7 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.6705 | n/a | 1 | Sep 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $12.56 | n/a | 6 | Aug 11, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $68 | $43.50 | n/a | 5 | Jun 8, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $332.38 | n/a | 1 | Jan 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $18 | $8.10 | n/a | 2 | Dec 9, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $24 → $20 | $0.0001 | n/a | 2 | May 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $47.79 | n/a | 1 | Jun 4, 2013 |
Summit Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $34
Current: $17.27
Upside: +96.87%
Benitec Biopharma
Sep 15, 2026
Reiterated: Buy
Price Target: $25
Current: $9.23
Upside: +170.86%
Scholar Rock Holding
Sep 15, 2026
Reiterated: Buy
Price Target: $65 → $72
Current: $43.40
Upside: +65.90%
BridgeBio Pharma
Sep 14, 2026
Reiterated: Buy
Price Target: $130
Current: $66.14
Upside: +96.55%
Moderna
Sep 11, 2026
Reiterated: Hold
Price Target: $50 → $80
Current: $203.21
Upside: -60.63%
Alnylam Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $325
Current: $219.89
Upside: +47.89%
Cytokinetics
Aug 31, 2026
Reiterated: Buy
Price Target: $100
Current: $62.70
Upside: +59.49%
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $230 → $320
Current: $207.68
Upside: +54.08%
Neurocrine Biosciences
Aug 17, 2026
Reiterated: Buy
Price Target: $210 → $215
Current: $144.21
Upside: +49.09%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $40
Current: $21.17
Upside: +88.95%
Aug 7, 2026
Reiterated: Buy
Price Target: $120
Current: $57.54
Upside: +108.55%
Aug 7, 2026
Reiterated: Buy
Price Target: $55
Current: $40.30
Upside: +36.48%
Aug 7, 2026
Reiterated: Buy
Price Target: $80
Current: $37.57
Upside: +112.94%
Aug 6, 2026
Reiterated: Buy
Price Target: $18 → $22
Current: $11.78
Upside: +86.76%
Aug 5, 2026
Reiterated: Buy
Price Target: $45
Current: $25.67
Upside: +75.30%
Aug 5, 2026
Reiterated: Buy
Price Target: $130
Current: $97.64
Upside: +33.14%
Aug 4, 2026
Reiterated: Buy
Price Target: $25
Current: $12.49
Upside: +100.16%
Aug 4, 2026
Reiterated: Buy
Price Target: $535
Current: $503.50
Upside: +6.26%
May 26, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $30.59
Upside: +63.45%
May 18, 2026
Reiterated: Buy
Price Target: $875 → $825
Current: $726.47
Upside: +13.56%
Mar 27, 2026
Downgraded: Hold
Price Target: $40 → $15
Current: $4.84
Upside: +209.92%
Mar 17, 2026
Reiterated: Buy
Price Target: $55
Current: $27.86
Upside: +97.42%
Jul 29, 2022
Reiterated: Buy
Price Target: $126 → $128
Current: $14.50
Upside: n/a
Jul 28, 2022
Reiterated: Hold
Price Target: $91 → $84
Current: $15.20
Upside: n/a
Jul 27, 2022
Reiterated: Hold
Price Target: $30 → $33
Current: $42.76
Upside: n/a
Jul 20, 2022
Reiterated: Hold
Price Target: $219 → $221
Current: $223.59
Upside: n/a
Jun 21, 2022
Downgraded: Hold
Price Target: $19
Current: $20.11
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: $14 → $11
Current: $2.88
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $24 → $20
Current: $1.50
Upside: n/a
May 4, 2022
Reiterated: Sell
Price Target: $19 → $16
Current: $2.79
Upside: n/a
Apr 28, 2022
Reiterated: Hold
Price Target: $235 → $227
Current: $402.98
Upside: n/a
Feb 9, 2022
Reiterated: Hold
Price Target: $98 → $86
Current: $114.13
Upside: n/a
Nov 19, 2021
Reiterated: Buy
Price Target: $61
Current: $18.78
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: n/a
Current: $18.91
Upside: n/a
Apr 29, 2021
Reiterated: Hold
Price Target: $74
Current: $144.63
Upside: n/a
Feb 25, 2021
Reiterated: Sell
Price Target: n/a
Current: $9.67
Upside: n/a
Jul 15, 2020
Downgraded: Sell
Price Target: n/a
Current: $81.44
Upside: n/a
Nov 13, 2019
Reiterated: Buy
Price Target: n/a
Current: $43.17
Upside: n/a
Jun 26, 2018
Reiterated: Sell
Price Target: n/a
Current: $0.29
Upside: n/a
May 11, 2017
Reiterated: Sell
Price Target: n/a
Current: $3.82
Upside: n/a
Apr 11, 2017
Reiterated: Buy
Price Target: $384 → $100
Current: $1,143.12
Upside: n/a
Dec 15, 2015
Reiterated: Buy
Price Target: $276.72
Current: $8.42
Upside: n/a
Dec 2, 2015
Rated: Buy
Price Target: $16
Current: $0.1442
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: n/a
Current: $0.7953
Upside: n/a
Sep 2, 2015
Initiated Coverage: Buy
Price Target: $20
Current: $0.6705
Upside: n/a
Aug 11, 2015
Reiterated: Buy
Price Target: $10 → $14
Current: $12.56
Upside: n/a
Jun 8, 2015
Reiterated: Hold
Price Target: $65 → $68
Current: $43.50
Upside: n/a
Jan 13, 2015
Reiterated: Hold
Price Target: n/a
Current: $332.38
Upside: n/a
Dec 9, 2014
Rated: Buy
Price Target: $20 → $18
Current: $8.10
Upside: n/a
May 7, 2014
Rated: Buy
Price Target: $24 → $20
Current: $0.0001
Upside: n/a
Jun 4, 2013
Downgraded: Hold
Price Target: n/a
Current: $47.79
Upside: n/a